Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
30 results loaded, newest first. More results are available. The latest changes are still being indexed. Try again shortly for updated results.
Stride reported first-quarter revenue of $639.4 million, up 3% year over year, while enrollment came in below expectations amid technology-platform issues affecting applications and new-student retention. The company forecast full-year revenue of $2.53 billion to $2.61 billion and adjusted operating income of $500 mill
For best results when printing this announcement, please click on link below: SOLVE FSHD Portfolio Company Altay Therapeutics Closes $37 Million Series A Financing to Advance DX5057 for FSHD Milestone follows nearly US$7 million in seed investment and strategic support from SOLVE FSHD SOLVE FSHD, a venture-philanthropy
Immunovant CEO Matthew Gline said the company expects to launch brepocitinib by the end of September, pending FDA action. The company also reported enrollment in a phase 3 cutaneous sarcoidosis study and outlined anticipated second-half data readouts.
For best results when printing this announcement, please click on link below: MedAxiom Releases 2026 Cardiovascular Provider Compensation & Production Survey Report, Revealing Record Compensation, Rising Productivity and Growing Workforce Demands National benchmarking report includes data from 205 cardiovascular progra
For best results when printing this announcement, please click on link below: Strong ROI for AI Nearly 3X More Common When Companies Measure Growth Versus Efficiency Alone, Wharton-GBK Study Finds Fourth annual study finds 80% of enterprise leaders report positive AI returns, but only 28% see strong ROI, as workflow tr
On Thursday, Cytokinetics (NASDAQ: CYTK ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary Cytokinetics reported strong commercial momentum for Myc
Galaxy Digital (NASDAQ: GLXY ) released second-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary Galaxy Digital reported a GAAP net loss of $85 mill
Galaxy Digital Hldgs (TSX: GLXY ) reported second-quarter financial results on Wednesday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary Full Transcript OPERATOR Goo
Bitcoin fell 3% to $83,098 and ethereum lost 5% to $2,564 as traders pointed to record-high Treasury yields and a stronger U.S. dollar. XRP and solana also declined in a broader crypto selloff.
The latest Market Talks covering Equities. Published exclusively on Dow Jones Newswires throughout the day. 1142 GMT - Burberry should continue to benefit from its strategic turnaround, but it isn't insulated from the broader sector context, AlphaValue's Jie Zhang says in a note. The British luxury group has showed enc
On Thursday, Chegg (NYSE: CHGG ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary Chegg Incorporated exceeded expectations on revenue, adjusted
Citi analysts view Informa's strategic plan to separate its academic markets business, Taylor & Francis, and acquire Clarion Events as a positive move that should create a higher growth business benefiting from structural tailwinds.
Oct 7 (Reuters) — The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines - Informa to buy rival events business Clarion from Blackstone for £2.2 billion - Asos investigating after app notification warned customers of 'hack' - Gol
Reuters listed M&A bids and deals reported by 0930 GMT Tuesday, including BPCE’s 7% Sabadell stake purchase, Informa’s £2.24 billion bid for Clarion, and KKR’s $5.1 billion deal for Gen II Fund Services, plus other transactions.
Informa PLC is planning to separate its academic publishing business, Taylor & Francis, which could lead to increased business volatility.
Iovance Biotherapeutics (NASDAQ: IOVA ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. Access the full call
Informa said it will acquire B2B events firm Clarion for £2.24 billion ($2.96 billion) and separate its academic publishing arm, Taylor & Francis, from the group. Clarkson forecast annual underlying pretax profit above market view, boosted by elevated freight rates.
Informa will acquire B2B events firm Clarion for £2.24 billion ($2.96 billion) and separate its academic publishing arm, Taylor & Francis, from the group. Informa has launched a formal review of all separation options for Taylor & Francis, which generates close to $1 billion in annual revenue.
Oct 6 (Reuters) — Informa PLC: Informa Plc - Growth, Focus & International Expansion Informa - Announces Plans To Separate Taylor & Francis Informa - To Buy Clarion In £2.24 Billion Deal Informa - Identifies £50 Million Annual Run Rate Operating Synergies Informa - Acquisition Expected To Enhance Adjusted Diluted Eps I
Informa announced plans to separate its academic business, Taylor & Francis, in order to concentrate on its core B2B operations.
Britain's Informa plans to separate its academic business, Taylor & Francis, to focus on its core B2B business.
Informa announced plans to separate its Academic Markets business, which includes Taylor & Francis.
Immunocore Hldgs (NASDAQ: IMCR ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Immunocore H
Insmed (NASDAQ: INSM ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Insmed reported strong
Amylyx Pharma (NASDAQ: AMLX ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summary Amylyx Pharma re
On Thursday, Roivant Sciences (NASDAQ: ROIV ) discussed first-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit The full earnings call is available at Summary Roivant Sciences reported a quiet
A new report by Busuu reveals that second-language anxiety is causing professionals to stay silent and miss opportunities at work. Nine in ten professionals (90%) prepare before high-stakes conversations by writing scripts or using translation apps, while only 24% use a language-learning app for this purpose.
The specialist dermatology and oncology company said it achieved first revenues from skin+CELL direct-to-consumer sales and completed a strategic acquisition of Swiss skincare brand énielle. It also said it raised gross proceeds of £355,000 through unsecured convertible loan notes.
Worldsec Limited reported an unaudited net loss of US$490,000 for the six months ended 30 June 2026, versus a loss of US$97,000 a year earlier. The company also said it appointed Elemental Company Secretary Limited as company secretary in September 2026.
IonQ and SDT have formed a multi-year strategic partnership to bring advanced quantum computing and quantum networking to the Asia-Pacific region. The collaboration will see IonQ supply SDT with a Superion 256 quantum computer and a silicon-vacancy quantum memory module for deployment in South Korea.